Drug
Rezdiffra
Rezdiffra: highest development phase Post-Market, developed by Madrigal Pharmaceuticals. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Madrigal Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| Rezdiffra NCT07848191 | Post-Market | MASH - Metabolic Dysfunction-Associated Steatohepatitis |
Latest
No recent events.
Follow Rezdiffra on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.